News

FDA’s Drug Office Handling Disputes, Complaints Goes Dark (1)
The FDA’s office that investigates complaints and disputes between reviewers and the drug industry is currently unavailable ...
US FDA limits industry employees from roles in its advisory committees
U.S. Food and Drug Administration Commissioner Martin Makary announced on Thursday a policy to limit employees of companies ...
STAT1dOpinion
Five priorities to remake the FDA in a time of deep uncertainty
Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...
STAT2d
Makary says FDA will remove pharma representatives from advisory panels
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them ...
Sudden dismissal of public records staff at health agencies threatens government accountability | The Conversation
Mass layoffs at the Department of Health and Human Services are continuing as the agency makes good on its intention, ...
News-Medical.Net3d
Who Takes the Blame When AI Makes a Medical Mistake?
This article examines the legal implications of AI in healthcare, focusing on liability issues and the need for clear accountability in medical AI applications.
The sudden dismissal of public records staff at health agencies threatens government accountability
Public records requested under the Freedom of Information Act have helped shape health policy and keep the government ...
Simulations Plus: Benefiting From FDA Modernization And AI
Simulations Plus leverages AI-driven tools to revolutionize drug discovery, cut R&D costs, and capitalize on FDA regulatory ...
When AI In Medical Devices Evolves Faster Than Regulations: How Do We Keep Up?
The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.